Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Pharmaceutical Potential of Gelatin as a pH-responsive Porogen for Manufacturing Porous Poly(d,l-lactic-co-glycolic acid) Microspheres

  • Received : 2010.07.13
  • Accepted : 2010.07.31
  • Published : 2010.08.20
Download PDF
⟨ Previous Next ⟩

Abstract

Porous poly(lactic-co-glycolic acid) microspheres (PLGA MS) have been utilized as an inhalation delivery system and a matrix scaffold system for tissue engineering. Here, gelatin (type A) is introduced as an extractable pH-responsive porogen, which is capable of controlling the porosity and pore size of PLGA microspheres. Porous PLGA microspheres were prepared by a water-in-oil-in-water ($w_1/o/w_2$) double emulsification/solvent evaporation method. The surface morphology of these microspheres was examined by varying pH (2.0~11.0) of water phases, using scanning electron microscopy (SEM). Also, their porosity and pore size were monitored by altering acidification time (1~5 h) using a phosphoric acid solution. Results showed that the pore-forming capability of gelatin was optimized at pH 5.0, and that the surface pore-formation was not significantly observed at pHs of < 4.0 or > 8.0. This was attributable to the balance between gel-formation by electrostatic repulsion and dissolution of gelatin. The appropriate time-selection between PLGA hardening and gelatin-washing out was considered as a second significant factor to control the porosity. Delaying the acidification time to ~5 h after emulsification was clearly effective to make pores in the microspheres. This finding suggests that the porosity and pore size of porous microspheres using gelatin can be significantly controlled depending on water phase pH and gelatin-removal time. The results obtained in this study would provide valuable pharmaceutical information to prepare porous PLGA MS, which is required to control the porosity.

Keywords

References

  1. Chung, H.J., Kim, H.K., Yoon, J.J., Park, T.G., 2006. Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. Pharm. Res. 23, 1835-1841. https://doi.org/10.1007/s11095-006-9039-9
  2. Cohen, S., Yoshioka, Y., Lucarelli, M., Hwang, L.H., Langer, R., 1991. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8, 713-720. https://doi.org/10.1023/A:1015841715384
  3. Edwards, D.A., Ben-Jebria, A., Langer, R., 1998. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physiol. 85, 379-385.
  4. Edwards, D.A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M.L., Mintzes , J., Deaver , D., Lotan, N., Langer, R., 1997. Large porous particles for pulmonary drug delivery. Science. 276, 1868-1871. https://doi.org/10.1126/science.276.5320.1868
  5. Gombotz, W.R., Pettit, D.K., 1995. Biodegradable polymers for protein and peptide drug delivery. Bioconjug. Chem. 6, 332-351. https://doi.org/10.1021/bc00034a002
  6. Kang, S.-W., Bae, Y.H., 2009. Cryopreservable and tumorigenic three-dimensional tumor culture in porous poly(lactic-co-glycolic acid) microsphere. Biomaterials. 30, 4227-4232 https://doi.org/10.1016/j.biomaterials.2009.04.025
  7. Kim, H.K., Chung, H.J., Park, T.G., 2006. Biodegradable polymeric microspheres with “open/closed” pores for sustained release of human growth hormone, J. Control. Release. 112, 167-174. https://doi.org/10.1016/j.jconrel.2006.02.004
  8. Kim, T.K., Yoon, J.J., Lee, D.S., Park, T.G., 2006. Gas foamed open porous biodegradable polymeric microspheres. Biomaterials. 27, 152-159. https://doi.org/10.1016/j.biomaterials.2005.05.081
  9. Kwon, M.J., Bae, J.H., Kim, J.J., Na, K., Lee, E.S., 2007. Long acting porous microparticles for pulmonary drug delivery. Int. J. Pharm. 333, 5-9.
  10. Lee, E.S., Kwon, M.J., Na, K., Bae, J.H., 2007. Protein release behavior from porous microparticle with lysozyme/hyaluronate ionic complex. Colloids Surfs. B. 55, 125-130. https://doi.org/10.1016/j.colsurfb.2006.11.024
  11. Park, H.I., Kim, H.U., Lee, E.S., Lee, K.C., Youn, Y.S., 2009. Preparation of Highly Porous Poly(d,l-lactic-co-glycolic acid) (PLGA) Microspheres. J. Kor. Pharm. Sci. 39, 167-171. https://doi.org/10.4333/KPS.2009.39.3.167
  12. Sun, L., Zhou, S., Wang, W., Li, X., Wang, J., Weng, J., 2009. Preparation and characterization of porous biodegradable microspheres used for controlled protein delivery. Colloids Surfs. A. 345, 173-181. https://doi.org/10.1016/j.colsurfa.2009.04.053
  13. Ungaro, F., De Rosa, G., Miro, A., Quaglia, F., Immacolata La Rotonda, M., 2006. Cyclodextrins in the production of large porous particles: Development of dry powders for the sustained release of insulin to the lungs. Eur. J. Pharm. Sci. 28, 423-432. https://doi.org/10.1016/j.ejps.2006.05.005
  14. Yang, Y., Bajaj, N., Xu, P., Ohn, K., Tsifansky, M.D., Yeo, Y., 2009. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials. 30, 1947-1953. https://doi.org/10.1016/j.biomaterials.2008.12.044
  15. Youn, Y.S., Lee, K.C., Bae, Y.H., Na, K., Lee, E.S., 2009. Advanced pulmonary delivery of peptides or proteins using polymeric particles in Delivery technologies for biopharmaceuticals: Peptides, proteins, nucleic acids, and vaccines. WILEY. 228-244.
  16. Young, S., Wong, M., Tabata, Y., Mikos, A.G., 2005. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release. 109, 256-274. https://doi.org/10.1016/j.jconrel.2005.09.023